Serious health risks are associated with DCM, even though it is one of the least
toxic simple
chlorohydrocarbons. Its high
volatility makes it an inhalation hazard. It can also be absorbed through the skin. Symptoms of acute overexposure to dichloromethane via inhalation include difficulty concentrating,
dizziness,
fatigue,
nausea,
headaches, numbness, weakness, and irritation of the
upper respiratory tract and
eyes. More severe consequences can include
suffocation,
loss of consciousness,
coma, and death. Acute exposure by inhalation has resulted in
optic neuropathy and
hepatitis. Prolonged skin contact can result in DCM dissolving some of the
fatty tissues in skin, resulting in skin irritation or
chemical burns. It may be
carcinogenic, as it has been linked to
cancer of the
lungs,
liver, and
pancreas in laboratory animals. Other animal studies showed
breast cancer and
salivary gland cancer. Research is not yet clear as to what levels may be carcinogenic to humans. In animal experiments, it was fetotoxic at doses that were maternally toxic but no
teratogenic effects were seen. In the
European Union, the
Scientific Committee on Occupational Exposure Limit Values (SCOEL) recommends an
occupational exposure limit for DCM of 100 ppm (8-hour time-weighted average) and a
short-term exposure limit of 200 ppm for a 15-minute period. The
European Parliament voted in 2009 to ban the use of DCM in paint-strippers for consumers and many professionals, with the ban taking effect in December 2010. In February 2013, the US
Occupational Safety and Health Administration (OSHA) and the
National Institute for Occupational Safety and Health warned that at least 14 bathtub refinishers have died since 2000 from DCM exposure. These workers had been working alone, in poorly ventilated bathrooms, with inadequate or no respiratory protection, and no training about the hazards of DCM. OSHA has since then issued a DCM standard. On March 15, 2019, the US
Environmental Protection Agency (EPA) issued a final rule to prohibit the manufacture (including importing and exporting), processing, and distribution of DCM in all paint removers for consumer use, effective in 180 days. However, it does not affect other products containing DCM, including many consumer products not intended for paint removal. On April 20, 2023, the EPA proposed a widespread ban on the production of DCM with some exceptions for military and industrial uses. On April 30, 2024, the EPA finalized a ban on most commercial uses of DCM, which mainly banned its application for stripping paint and degreasing surfaces but allowed for some remaining commercial applications, such as chemical production. The EPA (Environmental Protection Agency) finalized a ban on most uses of dichloromethane in April 2024. This ban, which took effect on July 8, 2024, prohibits most industrial and commercial uses of the chemical, including its use in paint removers for consumer use. New U.S. Environmental Protection Agency (EPA) regulations under the Toxic Substances Control Act (TSCA) have significantly lowered permissible exposure limits for dichloromethane to 2 ppm TWA and 16 ppm STEL, far below OSHA's existing standard (29 CFR 1910.1052). For remaining permitted uses, this necessitates a Workplace Chemical Protection Program (WCPP) requiring initial and periodic exposure monitoring at these much stricter levels to protect worker health. This EPA Final Rule (89 FR 39806) drives the new compliance requirements for monitoring. ==Environmental effects==